Montreal – April 3, 2026 – In the last few weeks, British Columbia and Ontario have approved access to HEMGENIX, gene therapy for hemophilia B. Decisions in other provinces...
By Sarah Ford The Canadian bleeding disorders community mourns the passing of longtime volunteer and advocate Marion Stolte, whose dedication and leadership helped improve the lives of people living...
The CHS has awarded three fellowships to attend the WFH World Congress in Malaysia this upcoming April. CLICK HERE to meet the 2026 Karttik Shah Fellowship recipients. CLICK HERE to meet...
The CHS has produced a new podcast series entitled NOVEL THERAPIES FOR BLEEDING DISORDERS. The series explores therapies that are potentially coming to the Canadian market for the treatment...